D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1151
GFL Environmental
GFL
$18.6B
| $18M | 0.01% |
431,608
+208,362
| +93% | +$8.91M |
2024 Q3
6 quarters
|
|
1152
Zions Bancorporation
ZION
$9.08B
| $18M | 0.01% |
312,096
-59,592
| -16% | -$3.51M |
2025 Q1
4 quarters
|
|
1153
CALL
Unity
U
$20.5B
| $18M | 0.01% |
819,500
-120,900
| -13% | -$3.35M |
2021 Q2
19 quarters
|
|
1154
Johnson Controls International
JCI
$94.8B
| $17.9M | 0.01% |
136,986
-135,779
| -50% | -$17.5M |
2018 Q3
30 quarters
|
|
1155
Sabra Healthcare REIT
SBRA
$4.93B
| $17.9M | 0.01% |
932,058
+275,680
| +42% | +$5.43M |
2024 Q2
7 quarters
|
|
1156
DELISTED
Esperion Therapeutics
ESPR
| $17.9M | 0.01% |
6,540,785
-362,698
| -5% | -$1.15M |
2025 Q3
2 quarters
|
|
1157
Healthcare Realty
HR
$5.9B
| $17.9M | 0.01% |
1,054,779
+680,035
| +181% | +$11.9M |
2021 Q4
17 quarters
|
|
1158
Hyatt Hotels
H
$15.4B
| $17.9M | 0.01% |
124,567
+109,238
| +713% | +$17.3M |
2022 Q1
16 quarters
|
|
1159
Replimune Group
REPL
$1.14B
| $17.9M | 0.01% |
2,336,528
-238,514
| -9% | -$1.82M |
2022 Q4
13 quarters
|
|
1160
Omnicell
OMCL
$1.66B
| $17.8M | 0.01% |
534,611
-377,343
| -41% | -$15.8M |
2022 Q2
15 quarters
|
|
1161
PUT
Baidu
BIDU
$28.5B
| $17.8M | 0.01% |
160,000
-611,900
| -79% | -$83M |
2013 Q2
51 quarters
|
|
1162
BioNTech
BNTX
$22.4B
| $17.8M | 0.01% |
199,768
-288,784
| -59% | -$29.7M |
2025 Q4
1 quarter
|
|
1163
Rayonier Advanced Materials
RYAM
$495M
| $17.6M | 0.01% |
1,594,055
+55,670
| +4% | +$502K |
2022 Q4
13 quarters
|
|
1164
Meritage Homes
MTH
$3.8B
| $17.6M | 0.01% |
285,336
+117,076
| +70% | +$8.27M |
2023 Q3
10 quarters
|
|
1165
iShares US Medical Devices ETF
IHI
$3.65B
| $17.6M | 0.01% |
329,189
+292,088
| +787% | +$17.2M |
2025 Q3
2 quarters
|
|
1166
Regeneron Pharmaceuticals
REGN
$77.5B
| $17.6M | 0.01% |
22,730
-132,745
| -85% | -$102M |
2013 Q2
51 quarters
|
|
1167
Collegium Pharmaceutical
COLL
$701M
| $17.6M | 0.01% |
530,698
-123,176
| -19% | -$5.22M |
2021 Q3
18 quarters
|
|
1168
Ormat Technologies
ORA
$5.6B
| $17.5M | 0.01% |
156,353
-45,384
| -22% | -$5.27M |
2022 Q2
15 quarters
|
|
1169
Avis
CAR
$3.8B
| $17.5M | 0.01% |
119,825
-80,455
| -40% | -$9.17M |
2024 Q1
8 quarters
|
|
1170
PUT
Flutter Entertainment
FLUT
$13.5B
| $17.4M | 0.01% |
171,100
+156,900
| +1,105% | +$22.6M |
2025 Q4
1 quarter
|
|
1171
IAMGOLD
IAG
$10.4B
| $17.4M | 0.01% |
925,673
-1,157,941
| -56% | -$23M |
2022 Q4
13 quarters
|
|
1172
Equifax
EFX
$17.5B
| $17.4M | 0.01% |
+96,685
| New | +$19.2M |
2026 Q1
0 quarters
|
|
1173
WaFd
WAFD
$2.17B
| $17.3M | 0.01% |
551,847
+193,949
| +54% | +$6.24M |
2025 Q2
3 quarters
|
|
1174
PUT
Humana
HUM
$50.5B
| $17.3M | 0.01% |
99,900
-89,600
| -47% | -$18.4M |
2023 Q4
9 quarters
|
|
1175
Sensient Technologies
SXT
$5.64B
| $17.3M | 0.01% |
200,281
-3,230
| -2% | -$302K |
2021 Q4
17 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.